Armata Pharmaceuticals, Inc.
ARMPNYSECIK 921114HealthcareFiscal year ends Dec 31
Reports and events: 330 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2307:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-109809 |
| 2026-09-1407:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-107253 |
| 2026-08-1216:23 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-094907 |
| 2026-08-1216:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-094896 |
| 2026-07-2007:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-084861 |
| 2026-07-2007:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-084860 |
| 2026-07-1307:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-082850 |
| 2026-06-2416:19 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001104659-26-077313 |
| 2026-06-2307:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-076627 |
| 2026-06-1616:43 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-074618 |
| 2026-05-1317:21 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-060384 |
| 2026-05-1316:49 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-060333 |
| 2026-05-1316:33 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-060299 |
| 2026-05-0707:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-056658 |
| 2026-04-2716:10 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001104659-26-049437 |
| 2026-04-2707:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-048997 |
| 2026-04-0216:16 ET | 8-K | 8.01 Other events | 0001104659-26-039180 |
| 2026-03-2516:18 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-034532 |
| 2026-03-2516:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-034523 |
| 2026-03-1907:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-031715 |
| 2026-02-2307:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-018333 |
| 2026-01-2616:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-26-002376 |
| 2026-01-2608:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-006446 |
| 2026-01-1307:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-003076 |
| 2025-12-0117:17 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-117387 |
| 2025-11-1216:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-110383 |
| 2025-11-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-110351 |
| 2025-10-2211:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-101447 |
| 2025-09-1118:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-089150 |
| 2025-08-1221:38 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-030666 |
| 2025-08-1216:36 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011235 |
| 2025-08-1216:16 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-011227 |
| 2025-06-1316:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-059346 |
| 2025-05-1907:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-050219 |
| 2025-05-1416:23 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007765 |
| 2025-05-1416:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007752 |
| 2025-05-0107:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-043017 |
| 2025-04-2817:01 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001104659-25-040273 |
| 2025-04-0216:05 ET | 8-K | 8.01 Other events | 0001104659-25-031127 |
| 2025-03-2120:32 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-003406 |
| 2025-03-2120:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-003405 |
| 2025-03-1217:49 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-008466 |
| 2025-03-1217:14 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-023015 |
| 2024-12-1907:38 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-129981 |
| 2024-12-0416:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-125505 |
| 2024-11-1516:05 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-119701 |
| 2024-11-1416:17 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-046918 |
| 2024-11-1316:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015530 |
| 2024-11-1316:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-015526 |
| 2024-11-1207:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-116327 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.